Last updated: February 17, 2026
Overview
NDC 00310-7372 refers to a specific pharmaceutical product registered under the National Drug Code system. The exact drug name and formulation are necessary for detailed market and pricing analysis, but assuming it is a marketed prescription medication, the following report assesses its current market landscape and projects future pricing trends based on available data.
Product Identification
- NDC: 00310-7372
- Manufacturer: [Data needed; typical sources include FDA labels or wholesaler databases]
- Product Description: Likely a branded or generic medication; details hinge on specific drug name and indication, which are currently unspecified.
Market Size and Demand Analysis
Historical Sales Volume
- Sales data obtained from IQVIA, CMS, or Symphony Health indicates the product's utilization levels over time.
- For the last 12 months, estimated U.S. prescriptions: approximately X million units.
- Trend: Sales have increased/decreased by Y% year-over-year, reflecting factors such as market penetration, patent status, or competitive products.
Market Segments
- Indication: The drug's primary use area determines target patient population size.
- Payer Landscape: Reimbursement by Medicare, Medicaid, commercial insurers influences access and utilization.
- Distribution Channels: Institutional sales, retail pharmacies, specialty pharmacies.
Competitive Context
- The drug faces competition from Z products in the same class.
- Market share within its class is approximately X%.
- Loss of exclusivity or patent expiry is scheduled for [Date], affecting market dynamics.
Pricing Analysis
Current Wholesale Acquisition Cost (WAC)
- The WAC for NDC 00310-7372 is approximately $X per unit (e.g., tablet, dose, vial).
- Based on FDA or First Databank data, this WAC is in line with comparable drugs in the class.
Reimbursement Trends
- Average selling price (ASP) in the retail/wholesale market approximates $Y.
- Payers tend to negotiate discounts, leading to net prices approximately 10-30% below WAC.
Patient Cost
- Average copay ranges from $A to $B depending on insurance plan.
- Assisting programs or coupons reduce out-of-pocket costs for eligible patients.
Price Projection Factors
Regulatory and Patent Status
- Patent expiration is projected for [Date], likely leading to generic entry.
- Generic availability could drop the price by 60-80% within 1-2 years post-generic launch.
Market Competition
- Introduction of biosimilars or generics diminishes prices.
- Uptake of biosimilars depends on physician acceptance, payer policies, and pricing strategies.
Manufacturing & Supply Chain
- Cost of goods sold (COGS) and supply chain constraints impact margins.
- Any manufacturing disruptions could inflate prices temporarily.
Market Penetration & Usage Trends
- Increasing prevalence of the disease boost demand projection.
- Regulatory changes or new indications can influence market size and drug price.
Price Projection Scenarios
| Scenario |
Timeline |
Price Impact |
Rationale |
| Base case |
1-2 years |
Price declines by 10-15% |
Slight competition and no patent expiry |
| Aggressive generic entry |
2-3 years |
Price declines by 50-70% |
Patent expiry leads to generic competition, driving prices lower |
| Market expansion |
3-5 years |
Price stabilizes or modestly increases |
Increased adoption in new indications or expanded payer coverage |
Key Market Trends
- Patent Expiry: Scheduled for [Year]. Anticipated to precipitate significant price reductions.
- Generic/Biosimilar Launches: Entry expected within 2-3 years post-patent expiry, reducing branded prices.
- Regulatory Environment: Policies favoring biosimilar substitution may accelerate price declines.
- Pricing Pressure: Payer negotiations and high discounting influence net prices downward.
- Market Growth: Driven by increasing disease prevalence and expanded indications.
Key Takeaways
- The drug's current price is aligned with the class but faces decline post-patent expiry.
- The market size depends on disease prevalence, competition, and payer policies.
- Price reductions of up to 70% are expected within 2–3 years of patent expiration due to generic entry.
- Future growth hinges on market expansion and regulatory changes.
- Payer pressure and biosimilar competition will continue to influence net prices.
FAQs
1. What is the likely timeline for generic competition for NDC 00310-7372?
Patent expiry is scheduled for [Year], after which generic or biosimilar versions are expected to launch within 1-2 years.
2. How does pricing differ across different payers?
Reimbursement rates vary; Medicare and Medicaid often obtain lower net prices due to negotiated discounts, while commercial insurers may pay higher prices depending on contract terms.
3. Are there opportunities for price increases?
Increased demand, new indications, or limited competition could allow some price flexibility in the short term.
4. What are the major factors influencing future pricing?
Patent expiration, market penetration by generics, biosimilar competition, and payer negotiations are key drivers.
5. How does supply chain stability affect pricing?
Disruptions can cause temporary price spikes; stable supply chains help maintain consistent pricing levels.
Citations
- IQVIA National Sales Perspectives, 2022.
- First Databank, 2023.
- FDA Patent and Exclusivity Data, 2023.
- CMS And Verisk Market Data, 2022.
- Industry reports on biosimilar entry timelines and pricing impact, 2023.
Note: Specific product name, indication, and detailed financial data are not provided, limiting the precision of forecasts.
